Atharva Polyplast GMP ₹7 ▲ 12.73%CSM Technologies GMP ₹4 ▲ 3.74%Turtlemint Fintech Solutions GMP ₹3 ▲ 2.08%Knack Packaging GMP ₹11.5 ▲ 7.14%Aastha Spintex GMP ₹5 ▲ 4.00%Twinkle Papers GMP ₹7 ▲ 10.94%Kratikal Tech GMP ₹17 ▲ 13.28%
By Sanjay Bambhaniya
May 7, 2026
SME | Book Build
Listed

Goldline Pharmaceutical SME IPO Allotment Status Link

₹41 - ₹43Price Band
₹12 Cr.Issue Size
3,000 sharesLot Size
PharmaceuticalsSector
Issue Open
May 12, 2026
Fresh Issue only
Issue Close
May 14, 2026
Min 2 lots (retail)
Allotment Date
May 15, 2026
Lot size: 3,000 shares
Listing Date
May 19. 2026
BSE SME
IPO DETAILS REVIEW GMP SUBSCRIPTION ALLOTMENT STATUS

The allotment process is the phase in which the company decides who gets the shares based on the total bids received. Goldline Pharmaceutical IPO investors wait to see if they get shares on the Allotment day, May 15, 2026. Goldline Pharmaceutical of approx. ₹12 crore opens on May 12, 2026. It includes the fresh issue of ₹12 Cr. and the Offer for Sale of ₹- Cr. These proceeds are to repay certain outstanding borrowings and for general corporate purposes. Retail investors must purchase a minimum of 2 lots of 3,000 shares each. This company works in pharmaceutical marketing and distribution.

Allotment Status

Check Allotment
Visit BigShare
Visit NSE / BSE
Your Brokerage App
Key Dates
Refunds
May 18, 2026
Demat Credit
May 18, 2026
Listing Date
May 19, 2026
✅ Allotment Success: Demat Shares Credit May 18, 2026 | ❌ Non-Allotment: IPO Funds Unblocking (Refund)
Trading from 10:00 AM

In case of non-allotment, most banks unblock the ASBA funds and provide refunds within 24 to 48 hours of the allotment/refund date. You can contact the registrar/bank if you do not get the refund in 7-10 working days.

How to Check Allotment Status

The official registrar for this IPO is Bigshare Services Pvt.Ltd They are responsible for the entire allotment process, refunds, and the share credit. You can check the status on three different platforms:

Method 1: Official Registrar Website

  • Visit Bigshare IPO portal.
  • Select ‘Goldline’.
  • Enter PAN or Application Number.
  • Submit.

Method 2: BSE / NSE Website

  • Go to BSE / NSE IPO Allotment.
  • Select Equity.
  • Enter Application Number and PAN.

Method 3: Demat Account

  • Log in to your broker (e.g., Zerodha)
  • ((Login Credentials)
  • Go to the IPO section.
  • Check the “My Applications” tab.

Get in touch with Bigshare Services Pvt.Ltd. for any concerns or queries related to allotment, refunds, or credit of shares. You can call on +91-22-6263 8200 or email at ipo@bigshareonline.com.

After Allotment: What's Next?

✅ Allotted Shares
May 18, 2026
Shares credited to your Demat account by end of day. Check under 'Holdings' in your broker app.
❌ Not Allotted
May 18, 2026
ASBA amount unblocked by your bank. Funds will reflect in your account within 1-2 business days.
📈 Listing Day Trading
May 19, 2026
Shares available for trading from market open (9:15 AM). You can sell on listing day.
Verify Demat Credit
Check broker app or CDSL/NSDL portal
Refund Timeline
Wait 24-48 hours post allotment
Listing Strategy
Decide hold or sell based on GMP

Frequently Asked Questions

How can I check the Goldline Pharmaceutical IPO allotment status?

You can check the allotment status on the registrar’s website, which is Bigshare Services Pvt.Ltd., by using your PAN card number or application number. You can also check on the BSE/NSE websites.

What is the refund initiation date for the IPO?

The refund process will start on May 18, 2026. The money blocked through ASBA will be unblocked on this date if you are not allotted shares.

When will the shares be credited to my Demat account?

The allotted shares will be credited to your Demat account on May 18, 2026, so you can trade them on the listing day.

What should I do if I don't get the refund?

If you do not receive the refund within 7-10 working days after the refund initiation date, you should contact the registrar, Bigshare Services Pvt.Ltd., or your bank.

Sanjay Bambhaniya
Sanjay Bambhaniya
Sanjay has 8+ years of experience in data-driven IPO insights. His expertise in digital marketing and web development complements his financial knowledge and helps him to develop effective fintech solutions. He is an entrepreneur and director who helps investors understand complex primary market trends in easy-to-understand IPO reports, news, and updates.
Discussion & Feedback
0 Comments

No comments yet. Be the first to share your thoughts!

Editorial Pickup

In the Spotlight

Important business websites and news channels talk about the IPO INDEX.

Media Feature

Logo